打破循环:矩阵金属蛋白酶抑制剂作为管理结核病发病和进展的替代方法
Agrim Jhilta1, Krishna Jadhav1, Raghuraj Singh1
1Pharmaceutical Nanotechnology Lab, Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, India 140306.
ACS infectious diseases
|July 22, 2024
概括
矩阵金属蛋白酶 (MMPs) 在结核病 (TB) 中驱动肺损伤. 抑制MMPs提供了一个有前途的宿主导疗法,以减少结核病患者的炎症和组织破坏.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 会导致严重的肺组织损伤和死亡.
- 矩阵金属蛋白酶 (MMPs) 有助于结核病的炎症性组织破坏和疾病进展.
- 在结核病中,MMP活性失调,损害了细胞外矩阵的完整性并促进了病理.
研究的目的:
- 审查MMPs在结核病发病和免疫反应中的作用.
- 探索MMP抑制剂作为结核病宿主导疗法的潜力.
- 总结针对结核病治疗中MMPs的新策略.
主要方法:
- 对MMP,TIMP和结核病研究的文献综述.
- 在Mtb感染中分析MMP表达,调节和功能.
- 评估涉及MMP抑制的治疗策略.
主要成果:
- 感染mtb的巨细胞诱导MMP的表达,破坏了ECM的恒常性.
- 免疫调节因素影响MMP分泌和颗粒瘤形成.
- 已经研究了内源性 (TIMPs) 和合成MMP抑制剂.
结论:
- MMP 抑制剂代表了结核病的有前途的宿主导治疗策略.
- 向MMP可以减轻与Mtb相关的矩阵破坏和肺炎.
- 针对MMP抑制剂的新型药物递送系统正在开发中,用于结核病治疗.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
相关概念视频
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I
228
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
228
Pulmonary Tuberculosis III
317
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
317
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
